platinum has been researched along with cimetidine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herbert, BH; Nelson, JA; Santos, G | 1 |
| Bonneterre, J; Dauplat, J; Fumoleau, P; Guastalla, JP; Kerbrat, P; Lhommé, C; Namer, M; Oberling, F; Pouillart, P; Tubiana, N | 1 |
| Katsuda, H; Katsura, H; Miyamoto, K; Nagata, N; Sai, Y; Waki, Y; Yamashita, M; Yu, J | 1 |
1 trial(s) available for platinum and cimetidine
| Article | Year |
|---|---|
Taxol (paclitaxel) safety in patients with platinum pretreated ovarian carcinoma: an interim analysis of a phase II multicenter study.
Topics: Adult; Aged; Chlorpheniramine; Cimetidine; Female; Humans; Infusions, Intravenous; Middle Aged; Ovarian Neoplasms; Paclitaxel; Platinum; Prednisolone; Premedication; Prospective Studies; Salvage Therapy; Stereoisomerism | 1994 |
2 other study(ies) available for platinum and cimetidine
| Article | Year |
|---|---|
Mechanisms for the renal secretion of cisplatin.
Topics: Animals; Binding, Competitive; Biological Transport, Active; Cimetidine; Cisplatin; In Vitro Techniques; Kidney; Male; Mice; Mice, Inbred AKR; p-Aminohippuric Acid; Platinum; Probenecid; Tetraethylammonium; Tetraethylammonium Compounds | 1984 |
Protecting cisplatin-induced nephrotoxicity with cimetidine does not affect antitumor activity.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Bone Neoplasms; Cell Line; Cell Line, Tumor; Cimetidine; Cisplatin; Infusions, Intravenous; Kidney; Male; Organic Cation Transport Proteins; Osteosarcoma; Platinum; Rats; Rats, Wistar; Reactive Oxygen Species; Renal Agents | 2010 |